Victor C Kok

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Venues

Cancer medicine

OncoTargets and therapy

PeerJ

Breast cancer (Dove Medical Press)

Asia University

Asia University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Asia University Sep 20 2014

Taiwan

Asst. Professor (part-time) :: Biomedical Informatics

Bureau of National Health Insurance Taichung Region Branch Jan 01 2004

Taiwan

Invited expert reviewer :: Medical Expenditure Review Unit

Kuang Tien General Hospital Oct 01 2003

Taiwan

Director of Cancer Center :: Cancer Center

Changhua Christian Hospital Jul 01 1994 - Oct 01 2003

Taiwan

Division chief :: Medical Oncology

Koo Foundation Sun Yat-Sen Cancer Center Jul 01 1992 - Jun 30 1994

Taiwan

Clinical Fellow :: Medical Oncology

Changhua Christian Hospital Jul 01 1989 - Jun 30 1992

Taiwan

Resident :: Department of Internal Medicine

Education History

Asia University Jan 01 2011 - Jun 30 2014

Taiwan

PHD :: Biomedical Informatics

Publications

Li-Ying Ko, Victor C Kok, Chun-Hao Tang, Chien-Kuan Lee, Pao-Sheng Yen
Successful Recanalization and Neurological Restoration in Cancerous Embolic Cerebral Infarction via Endovascular Stent-Retriever Embolectomy. OncoTargets and therapy 17 (2024)
Li-Ying Ko, Victor C Kok, Chun-Hao Tang, Chien-Kuan Lee, Pao-Sheng Yen
Successful Recanalization and Neurological Restoration in Cancerous Embolic Cerebral Infarction via Endovascular Stent-Retriever Embolectomy. OncoTargets and therapy 17 (2024)
Victor C Kok, To-Yu Huang, Yi-Chiung Hsu, Yuan-Ching Chang, Po-Sheng Yang
Select gene mutations associated with survival outcomes in ER-positive ERBB2-negative early-stage invasive breast cancer: A single-institutional tissue bank study. Cancer medicine 13 (14) (2024)
Victor C Kok, To-Yu Huang, Yi-Chiung Hsu, Yuan-Ching Chang, Po-Sheng Yang
Select gene mutations associated with survival outcomes in ER-positive ERBB2-negative early-stage invasive breast cancer: A single-institutional tissue bank study. Cancer medicine 13 (14) (2024)
Victor C Kok, To-Yu Huang, Yi-Chiung Hsu, Yuan-Ching Chang, Po-Sheng Yang
Select gene mutations associated with survival outcomes in ER-positive ERBB2-negative early-stage invasive breast cancer: A single-institutional tissue bank study. Cancer medicine 13 (14) (2024)
Ambily Sivadas, Victor C Kok, Ka-Lok Ng
Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers. Breast cancer research and treatment 193 (2) (2022)
Han-Wei Zhang, Zhi-Ren Tsai, Victor C Kok, Hsiao-Ching Peng, Yau-Hung Chen, Jeffrey J P Tsai, Chung Y Hsu
Long-term ambient hydrocarbon exposure and incidence of urinary bladder cancer. Scientific reports 12 (1) (2022)
Victor C Kok, Charles C N Wang, Szu-Han Liao, De-Lun Chen
Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer. Breast cancer (Dove Medical Press) 14 (2022)
Victor C Kok, Cheng-Chia Yu
Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development. International journal of nanomedicine 15 (2020)
Han-Wei Zhang, Victor C Kok, Shu-Chun Chuang, Chun-Hung Tseng, Chin-Teng Lin, Tsai-Chung Li, Fung-Chang Sung, Chi Pang Wen, Chao A Hsiung, Chung Y Hsu
Long-term ambient hydrocarbons exposure and incidence of ischemic stroke. PloS one 14 (12) (2019)
Victor C Kok, Paul R Winn, Yi-Jer Hsieh, Jien-Wen Chien, Jer-Ming Yang, Guang-Perng Yeh
A Pilot Survey of Potentially Hazardous Trace Elements in the Aquatic Environment Near a Coastal Coal-Fired Power Plant in Taiwan. Environmental health insights 13 (2019)
Victor C Kok, Yu-Ching Chen, Yang-Yuan Chen, Yu-Chieh Su, Ming-Chang Ku, Jung-Tsung Kuo, Go J Yoshida
Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study. Cancers 11 (7) (2019)
Hyun Cheol Chung, Victor C Kok, Rebecca Cheng, Yanzhi Hsu, Mauro Orlando, Charles Fuchs, Jae Yong Cho
Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer. Asia-Pacific journal of clinical oncology 14 (3) (2018)
Victor C Kok, Yi-Hsuan Hsiao, Jorng-Tzong Horng, Kung-Liang Wang
Association Between Erectile Dysfunction and Subsequent Prostate Cancer Development: A Population-Based Cohort Study With Double Concurrent Comparison Groups. American journal of men's health 12 (5) (2018)
Chien-Hung Huang, Jin-Shuei Ciou, Shun-Tsung Chen, Victor C Kok, Yi Chung, Jeffrey J P Tsai, Nilubon Kurubanjerdjit, Chi-Ying F Huang, Ka-Lok Ng
Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells. PeerJ 4 (2016)

Victor C Kok.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Victor C Kok